The muscle weakness in myasthenia gravis (MG) is caused by heterogeneous high-affinity IgG autoantibodies to the nicotinic acetylcholine receptor (AChR), a complex ion channel glycoprotein. 
Introduction
Myasthenia gravis (MG) is an organ-specific autoimmune extracellular aspects of the α subunits; some distinguish between fetal and adult AChR or show cross-reactivity with disease in which pathogenic IgG autoantibodies to the nicotinic acetylcholine receptor (AChR) lead to receptor loss and AChR from non-primate species (5) (6) (7) (8) (9) . Despite their clear involvement in disease pathogenesis, muscle weakness (reviewed in [1] [2] [3] . The AChR is a pentameric transmembrane glycoprotein ion channel, composed of α 2 βγδ little is known of the V region genes that encode the H and L chains of these antibodies, mainly because of the difficulty in (fetal) or α 2 βδε (adult) subunits (4) . Each subunit has a large, highly conformational extracellular domain at the N-terminus cloning human antibodies by conventional hybridoma technology (reviewed in 10). A few human monoclonal anti-AChR and four transmembrane regions. The α subunits bind ACh and the snake toxin α-bungarotoxin (α-BuTx). In MG, the antibodies have been generated from hybridomas (11-13), but none has been shown to immunoprecipitate detergentautoantibodies are measured by immunoprecipitation of detergent-extracted human AChR labeled with 125 I-α-BuTx.
extracted human AChR and some bound equally to Torpedo AChR, a specificity which is uncommon in MG sera (1, 8) , They are of high avidity (K D Ͻ10 -10 M), and heterogeneous in IgG subclass and light chain isotype, although IgG1 and questioning their relevance to the pathogenic autoantibodies.
There are now a number of different systems for cloning κ often predominate (5) . Variable proportions of the antibodies in different patients are directed against the 'main immunoand expressing Ig by recombinant techniques (reviewed in 14-16). We have constructed an Ig gene combinatorial library genic region' (MIR) and the α-BuTx-binding sites on the and expressed it using the Immunozap vector (as reviewed Tris, pH 8.0, containing 2 µg/ml aprotinin, 1 µg/ml leupeptin, 1 µg/ml pepstatin and 0.1 mM phenylmethylsulfonyl fluoride in 16). We used the thymus of a myasthenic patient, removed for therapeutic reasons, as a source of AChR-specific plasma (all from Sigma). The suspension was sonicated, membranes pelleted by centrifugation at 4000 g and the Fab protein was cell mRNA, because the thymus gland in young MG patients often shows lymphofollicular hyperplasia and is rich in plasma concentrated from the supernatant using a Protein G-Sepharose column (Pearce, UK). cells that spontaneously synthesize AChR autoantibodies with specificities similar to those in the serum (2, 3, (17) (18) (19) (20) (22) and an anti-sense primer corresSerum and Fab were serially diluted for testing against human, ponding to the 3Ј end of the IgG C H 1 domain (23) . Similarly, mouse and rat muscle AChR, and were tested undiluted a panel of sense oligonucleotide primers, designed to crossagainst Torpedo AChR. Results of precipitation by the approhybridize with all V κ gene families (24), and an antisense priate amount of healthy control serum or a Fab control were primer to the 3Ј end of the κ L chain (22) were used in L subtracted. chain DNA amplification. The primers incorporated restriction Epitope specificity of AB serum and Fab sites for cloning and the PCR was performed as previously described (22). PCR products were digested with XhoI-SpeI
To investigate the epitopes bound by AB serum, AChR was for the H chain and SacI-XbaI for the L chain, and ligated preincubated with mAb that bind to different epitopes on into the same sites in the Immunozap H and L bacteriophage human muscle AChR (30) and inhibition of AB serum binding λ vectors (Stratagene). The unamplified H and L chain libraries analyzed as previously described (8, 31) . Aliquots of 50 µl of each contained~5ϫ10 6 recombinants. Subsequently, the H 125 I-α-BuTx-labeled AChR were incubated overnight with each chain DNA (digested with HindIII and EcoRI) was ligated with mAb at 1 µl of ascites/ml, and 0.1 µl of AB serum was added κ chain DNA (digested with MluI and EcoRI) to yield a for 2 h at room temperature, followed by 15 µl goat anticombinatorial library of 7.23ϫ10 6 recombinants.
human Ig (pre-absorbed with 20% normal mouse serum to ensure that it did not immunoprecipitate the mAb) and 1 µl
Screening for AChR binding Fab and Fab expression
normal human serum (to act as carrier IgG). Results were expressed as percent inhibition: 100ϫ(c.p.m. precipitated The unamplified AB IgG1/κ combinatorial library was screened in XL1-Blue cells in conventional filter lift assays (25) by AB serum in the absence of mAb -c.p.m. precipitated by AB serum in the presence of mAb)/(c.p.m. precipitated by using human muscle AChR labeled with 2 nM 125 I-α-BuTx (Ͼ2000 Ci/mmol; Amersham International, Amersham, UK).
AB serum in the absence of mAb -c.p.m. precipitated by healthy control serum). Positive plaques were identified by autoradiography and cloned to homogeneity. Plasmids (BlueScript SK) were For Fab, the opposite approach was easier because our goat anti-mouse IgG did not precipitate Fab-AChR comexcised from the ImmunoZap vector using the helper phage R408 (Stratagene), and nucleotide sequencing of the Fab H plexes. Aliquots of 50 µl of each Fab were preincubated overnight with 50 µl 125 I-α-BuTx-human AChR, and then 0.1 and L chain inserts was performed in both directions by the dideoxynucleotide chain termination method (26) .
µl of each mAb was added and the incubation continued for 2-4 h at room temperature. mAb were then immunoprecipiFab were expressed as soluble proteins in XL1-Blue cells, as previously described (27 These results suggested that AB5 might bind to the γ nitrocellulose lifts. Both H and L chain variable sequences of subunit of the AChR that is characteristic of fetal or denervated AB1 and 2 proved to be completely identical (now called muscle. We therefore tested the serum and Fab for reactivity AB1/2). The V regions of the four Fab are most closely related with AChR extracted from TE671-γ (fetal-type) and TE671-ε to four different V H , three J H , two V κ and three J κ germline (adult-type) cells. AB serum and Fab AB1-4 reacted similarly genes ( Table 1) . Each V H showed at least 9 amino acid with adult-or fetal-type AChR (Fig. 3b and data not shown). differences from these sequences which, unlike the silent By contrast, AB5 bound much better to fetal-type AChR (Fig. nucleotide changes, tended to cluster in or near the comple3b). The specificity of AB1 for the α subunit, and of AB5 for mentarity determining region (CDR) 2 in AB4 and AB5 (Table the γ subunit, was confirmed by binding to AChR subunit 1 and Fig. 1 ). The CDR3s were particularly diverse, both in dimers generated in Xenopus oocytes and labeled with 125 Ilength and sequence, and we could not identify the original α-BuTx. Whereas AB1 bound equally well to both αγ and αε, germline D segments. Three of the light chains originated AB5 bound only to αγ and not to αε dimers (Fig. 3b) . from the V κ 3 family, two of them using the same DPK22.J κ 3 combination; there were more apparent mutations in AB1/2 Discussion than in the others (Fig. 1) . We next expressed the four AB Fab for characterization.
We have cloned four different AChR-specific autoantibodies from an Ig gene combinatorial library constructed from a MG Characterization of AB serum and Fab patient's thymus and expressed them as Fab. Despite their All Fab immunoprecipitated soluble 125 I-α-BuTx-labeled AChR monovalency, the Fab immunoprecipitated solubilized human from human muscle extracts (that contain both adult-and muscle AChR (concentration of AChR~1 nM), suggesting fetal-type AChR) in a dose-dependent manner. However, as the high affinity typical of MG serum antibodies (5), although expected, the apparent titers of active Fab in the concentrated further studies are required to confirm this point. Moreover, bacterial lysates were much lower than that of the polyclonal their fine specificities were similar to those found in the donor's IgG autoantibodies in AB's serum (Fig. 2a) . AB's serum serum in that two were directed against epitopes of the MIR showed considerable cross-reactivity with mouse and rat and one bound to an extracellular epitope of the γ subunit. AChR (Fig. 2b) but did not bind appreciably to Torpedo Hence these heterogeneous antibodies with their diverse AChR. Fab AB1/2 precipitated both mouse and rat AChR variable gene usage and frequent apparent mutations in the relatively well (but not Torpedo AChR), whereas AB3 greatly heavy chains are likely to reflect those expressed in vivo. preferred mouse AChR. AB4 and 5 bound much less to either
To clone the Fab we took advantage of the enrichment (Fig. 2b) . Neither the Fab nor serum from AB inhibited binding of plasma cells, with their abundant mRNA, after enzymic of 125 I-α-BuTx to human AChR or inhibited the function of dispersion of hyperplastic thymus (20). For screening λ phage AChR in TE671 cells (not shown).
plaques, we mimicked the immunoprecipitation assay for MG anti-AChR antibodies by using high specific activity 125 I-α-
AChR epitopes bound by AB serum and the Fab
BuTx to label human AChR. As in most MG sera (5,9), all four Fab preferentially recognized human AChR and the two tested The fine specificity of the anti-AChR antibodies in AB's serum and the Fab was investigated by competition with mAb that did not bind Torpedo AChR. Some human mAb obtained from hybridomas by others have shown specificity for electric fish recognize an epitope on the MIR of the human AChR α subunit (D6α), a partially overlapping α subunit epitope (C3α), AChR against which they were initially screened (11-13) and did not immunoprecipitate human AChR in the standard an epitope on the β subunit (B3β) or overlapping epitopes on the extracellular domain of the γ subunit (C2γ and B8γ). B3β assay. Such antibodies are clearly not typical of those present in MG sera. shows some cross-reactivity with the γ subunit (8 (Fig. 3a) . In addition~35% of AB's serum antibody was inhibited by mAb C2γ or B8γ. Little or no inhibition was found MG donor thymuses, they found only four distinct Fab. More- 
R:S ϭ replacement:silent mutations (total no. of substitutions resulting in codon changes:total no. of substitutions not resulting in codon changes). over, the three from one donor had clonally related heavy may bias against antibodies to the α-BuTx binding site. Nevertheless, the greater diversity obtained in our study of chains and two of these also had related light chains (39) . Since these Fab all bound to the MIR, phage display with IgG1 κ Fab from a single thymus is striking and consistent with previous observations that suggested greater diversity selection on immobilized AChR may bias against other specificities. Conversely, our use of 125 I-α-BuTx to label the AChR after selection by plaque screening than by phage display These specificities were represented in AB serum which showed strong cross-reactivity with mouse and rat AChR, and inhibition by the MIR-and γ subunit-specific mAb. We did not directly test the ability of the Fab to prevent binding of AB's serum antibody, but the inhibition studies with mAb indicate that they bound to the same or closely overlapping epitopes. Thus, we feel confident that the fine specificities of the Fab for extracellular AChR epitopes reflect those of donor AB. Anti-AChR antibodies in MG reduce numbers of functional AChR by three main mechanisms (40) . Antibodies to the ACh/ α-BuTx-binding sites are a minority in most patients but can be especially pathogenic (41) . However, none of the Fab caused inhibition of α-BuTx binding, an activity that would have complicated their initial detection and was not evident in the donor's serum. The two more common pathogenetic mechanisms are complement-mediated damage and accelerated degradation resulting from cross-linking and internalization of the AChR. Since our primer preferentially amplifies IgG1 sequences, the Fab must derive from a complementactivating subclass. Moreover, antibodies with MIR specificity are particularly efficient at modulating AChR from cell surfaces (42); thus the parent IgG of the MIR-reactive Fab (AB1/2 and AB3) might combine these two pathogenic properties.
A key question concerns the initiating stimulus to the autoanti-AChR response. Many patients, especially with earlyonset MG, have some anti-AChR antibodies that bind preferentially to fetal rather than adult AChR (5) . Their prevalence suggests a role for myoid cells in the thymus that express AChR of this isoform (43). Since the thymus usually also from four different V H genes in three families. That already argues strongly against the oligoclonal origin for these autoantibodies that has been suggested for some human autoimmune conditions (44, 45) and shown for DNA autoantibodies in a mouse model of systemic lupus erythematosus (46). Anti-(16). It will clearly be important to compare further the results of the two methods in MG and other autoimmune conditions. AChR Fab have now been cloned by three groups ( Table 2 ). None of the germline genes is the same, but those previously One criticism of any combinatorial approach is that the Fab H/L chain pairings obtained do not necessarily represent reported are from the V H 1 and V H 3 families. Fab AB3 is the first to use V H 4 genes, although they were abundantly those found in vivo. It is therefore important to test whether the Fab have similar specificities to serum antibodies. Several expressed in normal human thymus (47) . The V H gene DP42 encoding Fab AB1/2 is a polymorphic variant of 8-1B, the of the features that we observed in Fab AB1-5 mirrored those that are seen in MG. MG anti-AChR antibodies often show putative germline origin of some thyroid-peroxidase-specific Fab (27) . Furthermore, DP65 is the germline origin of both preference for fetal-rather than adult-type AChR, react variably with AChR from other species, and are heterogeneous AChR-specific Fab AB3 and a thyroglobulin-specific mAb (48). Two groups of V κ genes utilized by the AB Fab are in their fine specificity for the MIR and other epitopes as demonstrated by competition with mAb (5-9,31). Three of our abundant in the expressed repertoire, O2/O12 and A27/ humkv325/DPK22, and have been noted in other organFab did not distinguish between fetal-and adult-type AChR, but AB5 showed a marked preference for fetal-type AChR, specific autoantibodies; the former encodes numerous Fab specific for thyroid peroxidase (reviewed in 50) and the latter was able to inhibit binding of γ subunit-specific mAb and immunoprecipitated αγ dimers but not αε dimers. Differences encodes a human mAb to thyroglobulin (48). Finally, the heavy chains, in particular, showed many differin reactivity with mouse or rat AChR were clearly demonstrated by Fab1/2 and 3, even though they each showed specificity ences from the closest germline sequences; in AB4 and AB5, they tended to cluster in or near the CDR2s, as also noted for the MIR which is well conserved between species (7). by Graus et al. (39) for their Fab. The ratio of replacement to was a similar tendency in the L chain of AB1/2, though less so in the others. We found no obvious recurring motifs or silent mutations in these CDR2s is similar to those in other human mAb, as discussed by Chang and Casali (51). There convergent mutations, even when comparing with the equally
